We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAYS:NASDAQJ. W. Mays, Inc. Analysis

Data as of 2026-05-19 - not real-time

$41.05

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

J.W. Mays is trading at $41.05, just below its 20‑day SMA of 41.36 and 50‑day SMA of 41.76, while still above the 200‑day SMA of 39.99. The MACD shows a bullish signal with a positive histogram, and the RSI sits at 42, indicating a neutral momentum environment. Volume is on an increasing trend, and the stock is hovering near a support level of 40 with resistance around 42.72. Market sentiment is very optimistic, reflected by a Fear & Greed Index of Extreme Greed. However, the fundamentals are weak: the company posted a trailing EPS of -0.42, operating margins of -13.7%, and a gross margin of only 26.5%. Debt towers at $28.1 M versus cash of $0.43 M, yielding a debt‑to‑equity ratio of 54.2. The balance sheet pressure is compounded by a max drawdown of -27.7% and a 30‑day volatility of 21.3%, though the beta is low at 0.16. No dividend is paid, and the price‑to‑book ratio of 1.59 suggests the market is pricing in a premium despite the negative earnings. Overall, technical indicators hint at short‑term stability, but the financial health and high leverage raise significant concerns for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD histogram indicating short‑term momentum
  • Price near technical support at $40
  • Increasing trading volume supporting price stability

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Negative operating and profit margins
  • High debt load relative to cash and equity
  • Lack of earnings and zero EPS

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained leverage and debt‑to‑equity above 50
  • No dividend and weak cash generation
  • Sector cyclicality and exposure to real‑estate market downturns

Key Metrics & Analysis

Financial Health

Revenue Growth-7.70%
Profit Margin-3.90%
ROE-1.62%
ROA-0.87%
Debt/Equity54.19
P/B Ratio1.6
Op. Cash Flow$2.3M
Free Cash Flow$2.1M
Industry P/E32.1

Technical Analysis

TrendNeutral
RSI42.3
Support$40.00
Resistance$42.72
MA 20$41.36
MA 50$41.76
MA 200$39.99
MACDBullish
VolumeIncreasing
Fear & Greed Index88.93

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.26
Volatility21.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.